what's new
*Urgent tests and bedside service is also available for -
   -Blood Ketone bodies
  -Tropoin T Quantitative Tests
   (urgent reports within 1 hour)
*Computerised Radiography
*ENA profile
*Molecular tests
*Right Medical Centre(North Okkalapa)

  Upcoming Event
31 January 2016

 Health Fun Fair & Charity Bazaar
(With Shwe Yaung Hnin Si Cancer Foundation)
 Time : 3:00 pm - 6:00 pm
 Venue : People's Park, Pyay  Road, Yangon.
 

News Archive

Recent Medical Updates

Pulmonary metastasectomy: what is the practice and where is the evidence for effectiveness?

 
Tom Treasure, Mišel Milošević, Francesca Fiorentino, and Fergus Macbeth
 
Abstract
read more »
HLA-B27 Antigen:This is a blood test to detect the presence of HLA-B27 on lymphocytes (white blood cells). See also Histocompatibility antigens test.
read more »
New Classification and Update on the Quinolone Antibiotics : With the increasing number of available quinolone antibiotics, prescribing these drugs has become a challenge. Compared with older quinolones such as norfloxacin (Noroxin) and ciprofloxacin (Cipro), the newer agents have an expanded antimicrobial spectrum and new indications.
read more »
Serum Tumor Markers : Monoclonal antibodies are used to detect serum antigens associated with specific malignancies. These tumor markers are most useful for monitoring response to therapy and detecting early relapse. With the exception of prostate-specific antigen (PSA), tumor markers do not have sufficient sensitivity or specificity for use in screening.
read more »
Dynayax Presents Data From First Human Trial Or Inhaled ISS For Asthma At AAAAI : Dynavax Technologies today reported Phase I clinical data demonstrating the safety and biological activity of its inhaled ISS (immuno-stimulatory DNA sequence) for the treatment of asthma. The results were presented here at the 60th annual meeting of the American Academy of Allergy, Asthma & Immunology (AAAAI), along with preclinical data on mechanisms of action of ISS.
read more »
Dynavax Initiates Phase II Human Trial Of ISS For ASTHMA : Dynavax Technologies today announced it has initiated an exploratory Phase II clinical trial to evaluate the efficacy of its inhaled ISS (immunostimulatory DNA sequences) for the treatment of asthma.
read more »
FK 506 Tacrolimus : While the overall incidence of post-transplant lymphoproliferative disease (PTLD) in pediatric liver transplant recipients has been reported to be 4-11%, the long-term risk of PTLD associated with primary tacrolimus therapy is unknown. Therefore, in order to determine the incidence and long-term risk of PTLD, the present study examined 131 pediatric recipients who underwent liver transplantation (LTx) between October 1989 and December 1991 and received primary tacrolimus therapy.
read more »
GLIVEC, GLEEVEC : At a time when the era of blockbuster drugs, with annual sales of US$1 billion, is said to be on the wane, Novartis AG has seven potential blockbusters that could be on the market by 2008, executives said Wednesday during the company's annual research and development day in New York.
read more »
Histopathology : Lung cancer is still a disease of high mortality, despite advanced diagnostic techniques. Here, we aim to report a unique method to predict the recurrence and outcome of patients with pulmonary adenocarcinomas.
read more »
Urological Research : The expression of plasminogen- and colony-stimulating factor-1-associated markers was first investigated in seven bladder carcinoma cell lines and in 15 primary bladder tumors using RT-PCR (mRNAs), zymography (protein activity), ELISA and immunocytochemistry analysis (ICC) (protein levels).
read more »
Tumour Markers : The diagnosis of lung cancer and early knowledge of its histological type are very important; however, this is still a difficult subject for the physician. The aim of this study was to improve the diagnostic efficiency of tumour markers in the diagnosis of bronchial carcinoma by mathematical evaluation of a tumour marker profile employing fuzzy logic modelling.
read more »
All About HEPATITIS C : If you do test positive for hepatitis C, your doctor or the specialist to whom you've been referred will probably order a genotyping blood test. The hepatitis C virus has at least six distinct forms, or genotypes (labeled 1 through 6).
read more »
GENOME INSTITUTE OF SINGAPORE : Scientists from A*STAR's Genome Institute of Singapore (GIS) and the National University of Singapore (NUS) have developed a new synthetic protein fragment which can target and kill cancer cells.
read more »
Precore Mutant Chronic Hepatitis B -- Approach to Management : The diagnosis of precore mutant chronic hepatitis B (CHB) can be made with safety only by sequencing the precore region of the hepatitis B virus (HBV) genome, a method not widely available.
read more »
Response to Hepatitis C Therapy Can Last for Years : NEW YORK - A sustained response to successful treatment with interferon for hepatitis C virus (HCV) infection can persist for up to 12 years, according to a report in the November issue of the Journal of Medical Virology.
read more »
Straits Times - Singapore : S'pore team pioneers anti-cancer drugs They stop cells from multiplying and cause them to die, but more research is needed By Lee Hui Chieh
read more »
Response to Hepatitis C Therapy Can Last for Years : NEW YORK - A sustained response to successful treatment with interferon for hepatitis C virus (HCV) infection can persist for up to 12 years, according to a report in the November issue of the Journal of Medical Virology.
read more »